Stress and Drug Abuse: Epidemiology, Etiology, Prevention, and Treatment

The summary for the Stress and Drug Abuse: Epidemiology, Etiology, Prevention, and Treatment grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Stress and Drug Abuse: Epidemiology, Etiology, Prevention, and Treatment: The purpose of this RFA is to solicit applications for innovative research on chronic stress and drug abuse or dependence. Research is encouraged on the epidemiology, etiology, prevention, and treatment of drug abuse/dependence, as it relates to either chronic stress or Post Traumatic Stress Disorder (PTSD). More specifically, research is sought to examine the relationship between chronic stress or PTSD and drug use, abuse, and dependence. Also of interest is the relationship between chronic stress or PTSD and withdrawal/abstinence, remission, and relapse. The focus of this RFA is on drug abuse or dependence as they relate to chronic stress, not acute stress. Applications responsive to this RFA should include clearly articulated definitions of the chronic stress construct. Chronic stress has been operationalized and measured in various ways in relevant research. It is incumbent upon applicants to link proposed projects to a method of assessing/measuring chronic stress that meets conventional research standards (e.g., replicable, meets psychometric criteria for reliability) and is appropriate for the type of project that is proposed. Once developed, PTSD can be considered as a type of chronic stress (even though it may follow an acute stressor). In contrast to chronic stress, the construct of PTSD is associated with a generally accepted definition (i.e., a set of psychiatric diagnostic criteria developed by the American Psychiatric Association). Although NIMH is not a direct sponsor of this RFA, research (etiology, epidemiology, prevention and treatment) on chronic stress and PTSD as related to mental health and common comorbid conditions (e.g., substance use and abuse, delinquency, physical health) is of interest to NIMH.
Federal Grant Title: Stress and Drug Abuse: Epidemiology, Etiology, Prevention, and Treatment
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-04-001
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Jun 18, 2003
Posted Date: Jan 23, 2003
Creation Date: Jul 18, 2003
Archive Date: Jul 18, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com